A critical overview of the clinical evidence supporting the concept of neuroprogression in bipolar disorder

Psychiatry Research

Volumn 235, Issue , 2016, Pages 1-6

  Martino, Diego J ^a,b   Samamé, Cecilia ^a,b   Marengo, Eliana ^a,b   Igoa, Ana ^a   Strejilevich, Sergio A ^a,c  

^a FAVALORO UNIVERSITY   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c INSTITUTE OF COGNITIVE NEUROLOGY INECO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE;

BIPOLAR DISORDER; COGNITIVE DEFECT; COGNITIVE THERAPY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; MANIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOEDUCATION; RECURRENCE RISK; REVIEW; TREATMENT RESPONSE; COGNITION; DRUG RESISTANCE; PATHOPHYSIOLOGY;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COGNITION; DISEASE PROGRESSION; DRUG RESISTANCE; HUMANS;

EID: 84961753068     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.12.012     Document Type: Review

References (62)

1. Baldessarini R.J., Tondo L., Hennen J. Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord. 2003, 5(3):169-179.
2. Baldessarini R.J., Salvatore P., Khalsa H.M., Imaz-Etxeberria H., Gonzalez-Pinto A., Tohen M. Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients. J. Affect. Disord. 2012, 136:149-154.
3. Kraepelin, E., 1921. Psychiatrie: Ein Kurzes Lehrbuch für Studirende und Ärtze. In: Robertson, G.M. (Ed.) Barclay, R.M., translator. English translation of sections of Kraepelin's 1920 revision of the eighth edition of 1909, also revised in 1913. Manic-Depressive Insanity and Paranoia, E. and S. Livingstone, Edinburgh.
4. Berk M., Conus P., Lucas N., Hallam K., Malhi G.S., Dodd S., Yatham L.N., Yung A., McGorry P. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007, 9(7):671-678.
5. Berk M., Hallam K.T., McGorry P.D. The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J. Affect. Disord. 2007, 100:279-281.
6. Berk M. Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int. J. Neuropsychopharmacol. 2009, 12:441-445.
7. Berk M., Brnabic A., Dodd S., Kelin K., Tohen M., Malhi G.S., Berk L., Conus P., McGorry P.D. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011, 13(1):87-98.
8. Berk M., Kapczinski F., Andreazza A.C., Dean O.M., Giorlando F., Maes M., Yücel M., Gama C.S., Dodd S., Dean B., Magalhães P.V., Amminger P., McGorry P., Malhi G.S. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 2011, 35:804-817.
9. Berk M., Berk L., Dodd S., Cotton S., Macneil C., Daglas R., Conus P., Bechdolf A., Moylan S., Malhi G.S. Stage managing bipolar disorder. Bipolar Disord. 2014, 16(5):471-477.
10. Burdick K.E., Russo M., Frangou S., Mahon K., Braga R.J., Shanahan M., Malhotra A.K. Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol. Med. 2014, 44(14):3083-3096.
11. Cardoso T., Bauer I.E., Meyer T.D., Kpaczinski F., Soares J.C. Neuroprogression and cognitive functioning in bipolar disorder: a systematic review. Curr. Psychiatry Rep. 2015, 17(9):605. 10.1007/s11920-015-0605-x.
12. Cohen P., Cohen J. The clinician illusion. Arch. Gen. Psychiatry 1984, 41(12):1178-1182.
13. Coryell W., Endicott J., Keller M. Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch. Gen. Psychiatry 1992, 49(2):126-131.
14. Cosci F., Fava G.A. Staing of mental disorders: systematic review. Psychother. Psychosom. 2013, 82:20-34.
15. Franchini L., Zanardi R., Smeraldi E., Gasperini M. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249(5):227-230.
16. Frank E., Nimgaonkar V.L., Phillips M.L., Kupfer D.J. All the world a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol. Psychiatry 2015, 20:23-31.
17. Fries G.R., Pfaffenseller B., Stertz L., Paz A.V., Dargél A.A., Kunz M., Kapczinski F. Staging and neuroprogression in bipolar disorder. Curr. Psychiatry Rep. 2012, 14(6):667-675.
18. Gama C.S., Kunz M., Magalhães P.V., Kapczinski F. Staging and neuroprogression in bipolar disorder: a systematic review of the literature. Rev. Bras. Psiquiatr. 2013, 35:70-74.
19. Gitlin M.J., Swendsen J., Heller T.L., Hammen C. Relapse and impairment in bipolar disorder. Am. J. Psychiatry 1995, 152(11):1635-1640.
20. Kapczinski F., Dias V.V., Kauer-Sant'Anna M., Frey B.N., Grassi-Oliveira R., Colom F., Berk M. Clinical implications of a staging model for bipolar disorders. Expert Rev. Neurother. 2009, 9(7):957-966.
21. Kapczinski F., Magalhães P.V., Balanzá-Martinez V., Dias V.V., Frangou S., Gama C.S., Gonzalez-Pinto A., Grande I., Ha K., Kauer-Sant'Anna M., Kunz M., Kupka R., Leboyer M., Lopez-Jaramillo C., Post R.M., Rybakowski J.K., Scott J., Strejilevich S., Tohen M., Vazquez G., Yatham L., Vieta E., Berk M. Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr. Scand. 2014, 130(5):354-363.
22. Keck P.E., McElroy S.L., Strakowski S.M., West S.A., Sax K.W., Hawkins J.M., Bourne M.L., Haggard P. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am. J. Psychiatry 1998, 155(5):646-652.
23. Kessing L.V., Andersen P.K., Mortensen P.B., Bolwig T.G. Recurrence in affective disorder. I. Case register study. Br. J. Psychiatry 1998, 172:23-28.
24. Kessing L.V., Mortensen P.B., Bolwig T.G. Clinical definitions of sensitisation in affective disorder: a case register study of prevalence and prediction. J. Affect. Disord. 1998, 47:31-39.
25. Kessing L.V., Olsen E.W., Andersen P.K. Recurrence in affective disorder: analyses with frailty models. Am. J. Epidemiol. 1999, 149(5):404-411.
26. Kessing L.V., Andersen P.K. The effect of episodes on recurrence in affective disorder: a case register study. J. Affect. Disord. 1999, 53:225-231.
27. Kessing L.V., Hansen M.G., Andersen P.K., Angst J. The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective. Acta Psychiatr. Scand. 2004, 109(5):339-344.
28. Kessing L.V., Hansen M.G., Andersen P.K. Course of illness in depressive and bipolar disorders: naturalistic study, 1994-1999. Br. J. Psychiatry 2004, 185:372-377.
29. Lam D.H., Burbeck R., Wright K., Pilling S. Psychological therapies in bipolar disorder: the effect of illness history on relapse prevention - a systematic review. Bipolar Disord. 2009, 11:474-482.
30. Lee R.S., Hermens D.F., Scott J., Redoblado-Hodge M.A., Naismith S.L., Lagopoulos J., Griffiths K.R., Porter M.A., Hickie I.B. A meta-analysis of neuropsychological functioning in first-episode bipolar disorders. J. Psychiatr. Res. 2014, 57:1-11.
31. López-Jaramillo C., Lopera-Vásquez J., Gallo A., Ospina-Duque J., Bell V., Torrent C., Martínez-Arán A., Vieta E. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord. 2010, 12(5):557-567.
32. Magalhães P.V., Dodd S., Nierenberg A.A., Berk M. Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Aust. N. Z. J. Psychiatry 2012, 46(11):1058-1067.
33. Maj M., Magliano L., Pirozzi R., Marasco C., Guarneri M. Validity of rapid cycling as a course specifier for bipolar disorder. Am. J. Psychiatry 1994, 151(7):1015-1019.
34. Maj M., Pirozzi R., Magliano L. Late non-response to lithium prophylaxis in bipolar patients: prevalence and predictors. J. Affect. Disord. 1996, 39(1):39-42.
35. Maj M. The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord. 2000, 2(2):93-101.
36. Martino D.J., Strejilevich S.A., Marengo E., Igoa A., Fassi G., Teitelbaum J., Caravotta P. Relationship between neurocognitive functioning and episode recurrences in bipolar disorder. J. Affect. Disord. 2013, 147(1-3):345-351.
37. Martino D.J., Strejilevich S.A., Marengo E., Ibañez A., Scápola M., Igoa A. Toward the identification of neurocognitive subtypes in euthymic patients with bipolar disorder. J. Affect. Disord. 2014, 167:118-124.
38. Martino D.J., Samamé C., Ibañez A., Strejilevich S.A. Neurocognitive functioning in the premorbid stage and in the first episode of bipolar disorder: a systematic review. Psychiatry Res. 2015, 226(1):23-30.
39. McGorry P.D., Hickie I.B., Yung A.R., Pantelis C., Jackson H.J. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust. N. Z. J. Psychiatry 2006, 40:616-622.
40. McGorry P.D. Staging in neuropsychiatry: a Heuristic model for understanding, prevention and treatment. Neurotox. Res. 2010, 18:19-30.
41. McNamara R.K., Nandagopal J.J., Strakowski S.M., DelBello M.P. Preventative strategies for early-onset bipolar disorder: towards a clinical staging model. CNS Drugs 2010, 24(12):983-996.
42. Obrocea G.V., Dunn R.M., Frye M.A., Ketter T.A., Luckenbaugh D.A., Leverich G.S., Speer A.M., Osuch E.A., Jajodia K., Post R.M. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol. Psychiatry 2002, 51:253-260.
43. Oepen G., Baldessarini R.J., Salvatore P., Slater E. On the periodicity of manic-depressive insanity, by Eliot Slater (1938): translated excerpts and commentary. J. Affect. Disord. 2004, 78:1-9.
44. Perlis R.H., Ostacher M.J., Patel J.K., Marangell L.B., Zhang H., Wisniewski S.R., Ketter T.A., Miklowitz D.J., Otto M.W., Gyulai L., Reilly-Harrington N.A., Nierenberg A.A., Sachs G.S., Thase M.E. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am. J. Psychiatry 2006, 163(2):217-224.
45. Post R.M., Fleming J., Kapczinski F. Neurobiological correlates of illness progression in the recurrent affective disorders. J. Psychiatr. Res. 2012, 46:561-573.
46. Reinares M., Colom F., Rosa A.R., Bonnín C.M., Franco C., Solé B., Kapczinski F., Vieta E. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J. Affect. Disord. 2010, 123:81-86.
47. Reinares M., Papachristou E., Harvey P., Mar Bonnín C., Sánchez-Moreno J., Torrent C., Ayuso-Mateos JL., Ploubidis GB., Vieta E., Frangou S. Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J. Affect. Disord 2013, 144(1-2):65-71.
48. Robinson L., Ferrier N. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord. 2006, 8:103-116.
49. Rodrigues A.A., Rosa A.R., Kunz M., Bruna A., Kapczinski F. Bipolar disorder: staging and neuroprogression. Psychiatr. Polska 2014, 48(2):231-243.
50. Rosa A.R., González-Ortega I., González-Pinto A., Echeburúa E., Comes M., Martínez-Àran A., Ugarte A., Fernández M., Vieta E. One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. Acta Psychiatr. Scand. 2012, 125:335-341.
51. Rosa A.R., Magalhães P.V., Czepielewski L., Sulzbach M.V., Goi P.D., Vieta E., Gama C.S., Kapczinski F. Clinical staging in bipolar disorder: focus on cognition and functioning. J. Clin. Psychiatry 2014, 75(5):e450-456.
52. Samamé C., Martino D.J., Strejilevich S.A. A quantitative review of neurocognition in euthymic late-life bipolar disorder. Bipolar Disord. 2013, 15(6):633-644.
53. Samamé C., Martino D.J., Strejilevich S.A. Longitudinal course of cognitive deficits in bipolar disorder: a meta-analytic study. J. Affect. Disord. 2014, 164:130-138.
54. Scott J., Paykel E., Morriss R., Bentall R., Kinderman P., Johnson T., Abbott R., Hayhurst H. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br. J. Psychiatry 2006, 188:313-320.
55. Slater E. Zur Periodik des manisch-depressiven Irreseins. Z. Gesamte Neurol. Psychiatr. 1938, 162:794-801.
56. Strakowski S.M., Keck P.E., McElroy S.L., West S.A., Sax K.W., Hawkins J.M., Kmetz G.F., Upadhyaya V.H., Tugrul K.C., Bourne M.L. Twelve-month outcome after a first hospitalization for affective psychosis. Arch. Gen. Psychiatry 1998, 55(1):49-55.
57. Swann A.C., Bowden C.L., Calabrese J.R., Dilsaver S.C., Morris D.D. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am. J. Psychiatry 1999, 156:1264-1266.
58. Tohen M., Zárate C.A., Hennen J., Khalsa H.M., Strakowski S.M., Gebre-Medhin P., Salvatore P., Baldessarini R.J. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am. J. Psychiatry 2003, 160(12):2099-2107.
59. Torres I.J., DeFreitas V.G., DeFreitas C.M., Kauer-Sant'Anna M., Bond D.J., Honer W.G., Lam R.W., Yatham L.N. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J. Clin. Psychiatry 2010, 71(9):1234-1242.
60. Turvey C.L., Coryell W.H., Solomon D.A., Leon A.C., Endicott J., Keller M.B., Akiskal H. Long-term prognosis of bipolar I disorder. Acta Psychiatr. Scand. 1999, 99:110-119.
61. Vieta E., Reinares M., Rosa A.R. Staging bipolar disorder. Neurotox. Res. 2011, 19:279-285.
62. Vieta E., Popovic D., Rosa A.R., Solé B., Grande I., Frey B.N., Martinez-Aran A., Sanchez-Moreno J., Balanzá-Martínez V., Tabarés-Seisdedos R., Kapczinski F. The clinical implications of cognitive impairment and allostatic load in bipolar disorder. Eur. Psychiatry 2013, 28:21-29.